Showing results (41-50 of 291) with videos related to
Sort By:
Pageof 30
Clinical Imaging|February 10, 2018
Multicenter, multivendor phantom study to validate proton density fat fraction and T2* values calculated using vendor-provided 6-point DIXON methodsTatsuya Hayashi, Kei Fukuzawa, Hidekazu Yamazaki, et al.Intervirology|July 30, 2002
Influence of hepatitis C virus subtype on hepatocellular carcinogenesis: a multivariate analysis of a retrospective cohort of 593 patients with cirrhosisKenji Ikeda, Masahiro Kobayashi, Takashi Someya, et al.Radiology|March 27, 2015
Influence of Gadoxetate Disodium on Oxygen Saturation and Heart Rate during Dynamic Contrast-enhanced MR ImagingTatsuya Hayashi, Satoshi Saitoh, Yoshinori Tsuji, et al.Cureus|November 26, 2024
An Evaluation of the Most Convenient and Effective Procedure for Reducing the Loading Time of Epirubicin Into the Drug-Eluting Bead M1 (DC Bead M1™)Yusuke Kawamura, Norio Akuta, Shigeki Yamamoto, et al.Journal of Pharmaceutical Sciences|August 14, 2017
Recent Topics of Research in the Characterization and Quality Control of Biopharmaceuticals in JapanAkiko Ishii-Watabe, Hiroko Shibata, Akira Harazono, et al.Biologicals : Journal of the International Association of Biological Standardization|December 17, 2018
Interlaboratory comparison about feasibility of insoluble particulate matter test for injections with reduced test volume in light obscuration methodAkira Harazono, Hiroko Shibata, Masato Kiyoshi, et al.Journal of Gastroenterology|December 17, 2002
Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapyFumitaka Suzuki, Akihito Tsubota, Norio Akuta, et al.Journal of Hepatology|December 14, 2002
Long-term prognosis by lamivudine monotherapy for severe acute exacerbation in chronic hepatitis B infection: emergence of YMDD motif mutant and risk of breakthrough hepatitis -- an open-cohort studyNorio Akuta, Akihito Tsubota, Fumitaka Suzuki, et al.Journal of Gastroenterology|October 22, 2003
Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosisKenji Ikeda, Yasuji Arase, Masahiro Kobayashi, et al.Intervirology|September 17, 2005
Anticarcinogenic impact of interferon on patients with chronic hepatitis C: a large-scale long-term study in a single centerKenji Ikeda, Yasuji Arase, Satoshi Saitoh, et al.Pageof 30